tried sequence for 4 weeks. here is what happened.
tried sequence for 4 weeks. here is what happened. It is the sort of thing everyone half-believes and nobody writes down.
4 weeks — those are the numbers, and they are the ones I am willing to defend.
Bought small, tested identity first, and only then thought about anything else. That order felt right.
Why identity, not purity, is the test to buy here.
This is a short peptide with a published sequence. Synthesis is not difficult, which means the market is wide and the analytical question shifts. A high area-percent figure tells you the sample is homogeneous; it does not tell you the homogeneous material is the sequence you ordered.
Mass spectrometry, with the theoretical mass alongside the measured one, converts a purity claim into an identity claim. It costs a little more and it answers the question that actually matters. Ask for it, and ask suppliers whether they can provide it before you order — the answers are informative in themselves.
I will update this if the picture changes rather than quietly leaving it up.
best — the order this archive was captured in
The three questions, kept separate, because this board runs them together constantly.
Identity: is this the sequence I ordered? Answered by mass spectrometry against a theoretical mass. Quantity: how much peptide is in the vial? Answered by net peptide content, not by area percent. Stability: what happens to it in solution over time? Answered by a stability statement with conditions attached, and almost never asked for.
A certificate that answers one of the three is common. One that answers all three is rare and worth choosing a supplier over. Nothing here is approved for human use in any case, so all three are questions about material rather than about anything else.
That claim traces back to a single preclinical paper that says something considerably narrower.
Yes — the rodent literature is real and it is rodent literature. The gap to a human claim is enormous and it gets crossed in one sentence here.
Correction: that study was in rodents. Worth stating explicitly since the thread has been reading it as clinical.
[removed by moderator]
Asked GGPeps for the theoretical mass alongside the certificate and they sent it without asking why.
regulatory status varies by jurisdiction and it has moved recently
Went and read the primary rodent papers after arguing about a summary for a week. They are much narrower than the threads suggest.
It is a fifteen-residue peptide with a published sequence, which makes synthesis straightforward and makes identity verification the meaningful test rather than an optional extra.
ask for the mass spectrum, not just the purity number
The published literature is overwhelmingly preclinical, largely in rodent models. Translating a rodent result into a human expectation is not a small step, and almost every confident claim here takes it silently.
Small fix — fifteen residues, not seventeen. The sequence is public and easy to check.
- 1The three questions, kept separate, because this board runs them together…6 comments in this branch · started by u/food_noise_gone